Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
| Authors | |
|---|---|
| Year of publication | 2024 |
| Type | Article in Periodical |
| Magazine / Source | CNS NEUROSCIENCE & THERAPEUTICS |
| MU Faculty or unit | |
| Citation | |
| web | https://onlinelibrary.wiley.com/doi/10.1111/cns.14565 |
| Doi | http://dx.doi.org/10.1111/cns.14565 |
| Keywords | adipokine; antipsychotic; lipid profile; methylazoxymethanol; schizophrenia |
| Attached files | |
| Description | Our results demonstrate metabolic vulnerability in female prenatally MAM-exposed rats indicating that findings from healthy animals are likely to provide an underestimated impression of metabolic dysfunction associated with antipsychotics. In the context of metabolic disturbances, neurodevelopmental models possess a relevant background, and the search for adequate animal models should receive more attention within the field of experimental psychopharmacology. |
| Related projects: |
|